GWM
ASXC

Geneos Wealth Management’s Asensus Surgical, Inc. ASXC Stock Holding History

Geneos Wealth Management’s Portfolio ASXC Stock Details ASXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,100
Closed -$561 – 2153
2023
Q2 		$561 Hold
1,100
– – ﹤0.01% 2062
2023
Q1 		$726 Buy
+1,100
New +$745 ﹤0.01% 2025
2022
Q2 		– Sell
-1,100
Closed – – 2821
2022
Q1 		$0 Sell
1,100
-14,425
-93% -$11.1K ﹤0.01% 3022
2021
Q4 		$17K Buy
15,525
+13,400
+631% +$20.7K ﹤0.01% 1983
2021
Q3 		$3K Hold
2,125
– – ﹤0.01% 2609
2021
Q2 		$6K Sell
2,125
-107
-5% -$267 ﹤0.01% 2419
2021
Q1 		$4K Buy
2,232
+132
+6% +$478 ﹤0.01% 2756
2020
Q4 		$7K Buy
+2,100
New +$960 ﹤0.01% 2389

Other funds holding ASXC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AA
AlphaCentric Advisors San Juan, Puerto Rico $118M AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Geneos Wealth Management's ASXC Position: Q3 2023 in Review

Geneos Wealth Management sold out of Asensus Surgical, Inc. (ASXC) in Q3 2023, closing a stake of 1,100 shares — an estimated $561 sold.

Geneos Wealth Management first reported a position in ASXC in Q4 2020 and held it in 8 quarters. The position peaked at $17K in Q4 2021. 68 funds tracked by Wall St. Rank hold ASXC as of Q3 2023.

  • Geneos Wealth Management reported no remaining Asensus Surgical, Inc. position as of Q3 2023 after selling out during the quarter.
  • Geneos Wealth Management sold 1,100 Asensus Surgical, Inc. shares in Q3 2023, an estimated $561.
  • Geneos Wealth Management first reported a position in Asensus Surgical, Inc. in Q4 2020 and held it in 8 quarters.
  • Geneos Wealth Management's Asensus Surgical, Inc. position peaked at $17K in Q4 2021.
  • 68 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q3 2023.

Based on Geneos Wealth Management's 13F filing for Q3 2023, filed 11 Oct 2023.